Abstract:In the late 1960s, ultrafiltration was first used in clinical settings to increase, by convection, the clearance of toxic solutes in patients undergoing dialysis. Unfortunately, the efficiency of convection-based dialysis treatment, or hemofiltration (HF), was limited by the relatively low ultrafiltration coefficient of the dialyzers available at the time. Thus, the exchanged volume was low, and the corresponding clearance of low-molecular-weight solutes was insufficient with respect to the current target value of Kt/V urea. This was probably the cause of the failed improvement in the clinical and metabolic status of patients compared with standard dialysis treatment. In 1977, favorable results of the combination of diffusion and convection demonstrated the potential advantage of hemodiafiltration (HDF) over HF in terms of dialysis clearance. HDF was in fact the only means to obtain significant clearance of high-molecular-weight solutes while maintaining adequate urea clearance, whereas the increase in mean hematocrit in the erythropoietin era limited the exchanged volume in HF, in spite of the improved water permeability of the dialysis membranes. Mixed diffusive and convective clearance is less than the sum of the two parts because of reciprocal interference. Diffusive clearance mainly depends on the membrane permeability and the solute concentration gradient. New, highly permeable dialysis membranes can reach significant clearance of high-molecular-weight solutes such as Beta2 microglobulin (B2m) simply by diffusion, although in clinical settings there is also considerable ''hidden'' convection due to backfiltration. However, convection remains the best way to remove high-molecular-weight solutes, also for this kind of membrane. The ultrafiltration rate and the sieving coefficient account for the amount of convective clearance, as described in detail in the text. To define the treatment dose, the equation of Waniewsky allows the theoretical calculation of the urea clearance in HDF, both in postdilution and predilution mode. Unfortunately, no such equation is available for B2m. With a new mathematical model, well fitting with preliminary measured data although not fully validated, we calculated the relationship between urea and B2m clearance in predilution versus postdilution HDF, also considering the impact of variables such as blood and ultrafiltration flow. In particular, the predilution mode may decrease the urea clearance in comparison to hemodialysis with the same membrane and blood flow. This also applies to B2m clearance in predilution vs postdilution HDF, in spite of a marked increase in the ultrafiltration rate, at least in the more common clinical settings. In conclusion, good knowledge of the physics of solute transport is mandatory for appropriate prescription of HDF, in order to maximize both low- and high-molecular-weight solute clearance.

Effect of blood flow rate on solute clearance in high-dose pre-dilution continuous venovenous hemofiltration

[The Effects of Dialysate and Ultrafiltration Flow Rate on Solute Clearance During Continuous Renal Replacement Therapy].

Effects of High Blood Flow and High Pre-Dilution Replacement Fluid Rates on Small Solute Clearances in Hemofiltration

Optimization of Venous Return Tubing Diameter for Cardiopulmonary Bypass.

Effect of Blood and Dialysate Flow Rate on Solute Clearance at Low Dialysate Flow Rate in Daily Hemodialysis

Effects of different reuse methods of hemodialyzer on solute clearance rate in various continuous venovenous hemodiafiltration

COMPARATIVE STUDY OF SOLUTES CLEARANCES BETWEEN VARIOUS CONTINUOUS RENAL REPLACEMENT THERAPY METHODS

Solutes Removal Characteristics at Various Effluent Rates During Different Continuous Renal Replacement Therapy Modalities

Actually Delivered Dose of Continuous Renal Replacement Therapy is Underestimated in Hemofiltration.

[Evolution and physical principles of convection-based dialysis treatment]

Effect of the Application of Continuous Cenous Venous Hemofiltration on Pulmonary Vascular Permeability in the Early Stage of Septic Shock

The effect of continuous renal replacement therapy in patients with acute kidney injury on the serum levels of urea,creatinine and cystatin C

High- versus low-flux hemodialysis in removing solutes

New modes of continuous renal replacement therapy using a refiltering technique to reduce micronutrient loss

[The effect of increasing ventral movement on the small solutes transport during peritoneal dialysis]

Effects of filter reuse on solute clearance and safety in on-line hemodiafiltration

Clinical Application of High Flow Rate Modified Ultrafiltration

Protein Loss in Critically Ill Patients During Continuous Veno-Venous Hemofiltration

Application of Modified Ultrafiltration on Cardiopulmonary Bypass in Children

[A Comparison of High Versus Standard-Volume Hemofiltration in Critically Ill Children with Severe Sepsis].

Continuous Venovenous Hemofi Ltration with Citrate Based,calcium-,Mag Nesium-Free Replacement Solution in Acut E Renal Failure Patients at High Risk of Bleeding